Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance

On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. 

Non-GAAP core revenue increased by 0.5%, compared to the expectations of a decline in the low-single digits.

Danaher reported second-quarter adjusted EPS of $1.71, beating the consensus of $1.57.

Operating cash flow was $1.5 billion, and non-GAAP free cash flow was $1.2 billion.

Also Read: Danaher Is Poised For ‘A Good Year In Bioprocessing’: Analyst.

Rainer Blair, President and CEO, stated, “Our team delivered strong third-quarter results, including better-than-expected revenue growth. We ...